Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells

Leukemia

Volumn 19, Issue 2, 2005, Pages 223-229

  Renaudineau, Y ^a   Nedellec S ^a   Berthou, C ^a   Lydyard, P M ^b   Youinou, P ^a   Pers, J O ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apoptosis; BCR; CD5; Chronic lymphocytic leukemia; Lipid rafts

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CROSS LINKING; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNOPRECIPITATION; LIPID RAFT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 13544271140     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403601     Document Type: Article

References (24)

1. Lavabre-Bertrand T, Janossy G, Exbrayat C, Bourquard P, Duperray C, Navarro M. Leukemia-associated changes identified by quantitative flow cytometry.II. CD5 over-expression and monitoring in B-CLL. Leukemia 1994; 8: 1557-1563.
2. Dighiero G. Unsolved issues in CLL biology and management. Leukemia 2003; 17: 2385-2391.
3. Pers JO, Jamin C, Le Corre R, Lydyard PM, Youinou P. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis. Eur J Immunol 1998; 28: 4170-4176.
4. Pers JO, Berthou C, Porakishvili N, Burdjanadze M, Le Calvez G, Abgrall JF et al. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia 2002; 16 44-52.
5. Alfarano A, Indraccalo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R et al. Alternatively spliced form of CD79b may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood 1999; 93: 2327-2335.
6. Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, Liou HC et al. Survival of leukemic B cells by engagement of the antigen receptor. Blood 2001; 98: 3050-3057.
7. Cheng PC, Dykstra ML, Mitchell RN, Pierce SK. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 1999; 190: 1549-1560.
8. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to immunoglobulin genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639-1647.
9. Matutes E, Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemias and mature B-cell disorders. Leuk Lymphoma 1994; 13 (Suppl 1): 11-14.
10. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
11. MacKenzie LE, Lydyard PM. Epitope mapping of the CD5 molecule. In: Knapp W, Dörken B, Rieber EP, Stein H, Gilks WR, Schmidt RE, von dem Borne AEGKr (eds) Leucocyte Typing IV. Oxford: Oxford University Press, 1989, pp 336-337.
12. Cragg MS, Chan HT, Fox MD, Tutt A, Smith A, Oscier DG et al. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood 2002; 100: 3068-3076.
13. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98: 181-186.
14. Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002; 100: 4609-4614.
15. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today 1999; 20: 312-316.
16. Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 1996; 88: 1365-1374.
17. Zupo S, Dono M, Massara R, Taborelli G, Chiorazzi N, Ferrarrini M. Expression of CD5 and CD38 by human CD5-B cells: requirement for special stimuli. Eur J Immunol 1994; 24: 1426-1433.
18. Deaglio S, Capobianco A, Bergui L, Dürig J, Morabito F, Dührsen U et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003; 102: 2146-2155.
19. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20: 253-300.
20. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 151: 1848-1854.
21. Wiestner A, Rosenwald T, Barry TS, Wright G, Davis RE, Henrickson SE et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101: 4944-4951.
22. Gary-Gouy H, Lang V, Sarun S, Boumsell L, Bismuth G. In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes. J Immunol 1997; 159: 3739-3747.
23. Gary-Gouy H, Bruhns P, Schmitt C, Dalloul A, Daëron M, Bismuth G. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000; 275: 548-556.
24. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid microdomains in the apical plasma membrane. Nat Cell Biol 2000; 2: 582-592.